Intern, Global Marketing, Surgical Irrigation Platform jobs in United States
cer-icon
Apply on Employer Site
company-logo

BD · 3 weeks ago

Intern, Global Marketing, Surgical Irrigation Platform

BD is one of the largest global medical technology companies in the world, dedicated to advancing health. The internship in the Surgical Irrigation Platform offers hands-on experience in healthcare marketing, focusing on campaign development, sales data analysis, and collaboration with various teams to enhance surgical outcomes.

Health CareMedical DeviceTechnical Support
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Support campaign development and sales data analysis
Collaborate with U.S. and Global Marketing teams
Contribute to the development of customer-facing materials and manage the Veeva approval process
Identify gaps in product claims and help generate new claims based on clinical and/or scientific evidence
Support internal communications and dashboard creation

Qualification

Healthcare marketingData analysisCampaign developmentCross-functional collaborationCommunication skills

Required

High School Diploma or GED
Availability to work full time onsite at either Vernon Hills, IL or Warwick, RI
Availability to start as early as January 2026 with expected duration of roughly 12 months

Benefits

A valuable, competitive package of compensation and benefits programs
Rewards and recognition opportunities that promote a performance-based culture

Company

BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.

H1B Sponsorship

BD has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (66)
2022 (4)
2021 (3)

Funding

Current Stage
Public Company
Total Funding
$540M
Key Investors
Steris
2023-08-02Post Ipo Equity· $540M
1962-04-23IPO

Leadership Team

leader-logo
Tom Polen
Chairman, CEO and President
linkedin
leader-logo
Richard Byrd
Executive Vice President and President Interventional Segment
linkedin
Company data provided by crunchbase